Andera Partners
Edit

Andera Partners

https://www.anderapartners.com
Last activity: 16.01.2025
Active
Invests in categories: ServiceMedTechProductDevelopmentTechnologyManagementAdTechITDrugHardware
Créée en 2001, ANDERA PARTNERS, est une référence de l’investissement non coté en France et à l’international. Elle gère près de 2,5 milliards d’euros autour des sciences de la vie (Andera Life Sciences), du capital développement et de la transmission (Andera MidCap et Andera Expansion), de la dette mezzanine sponsorless (Andera Acto) et de la transition énergétique (Andera Infra).
News
175
Portfolio
245
Persons
137
Mentions
67
Location: France, Ile-de-France
Employees: 51-200
Investment Stage: Series A; Series B; Series C; Series E

Portfolio 245

DateNameWebsiteTotal RaisedLocation
17.03.2024Les Alchim...alchimistes.co-France, Il...
17.03.2024Terr.Aterr-a.fr--
27.01.2024Meogroupmeogroup-consulting.com--
10.01.2024Sanso Long...sanso-is.com--
10.01.2024Ingenostru...ingenostrum.com--
05.12.2023Imagerie C...imagerie-cardinet.fr-France, Il...
01.12.2023mylight150mylight150.com$108.9MMetropolit...
17.11.2023Groupe Gos...gosto.com-France, Ha...
14.11.2023Nouscom AGnouscom.com$135.77MSwitzerlan...
27.10.2023EFORefor-group.com-Metropolit...
Show more

Persons 137

DateFirst NameLast NameTitleLinkedInLocation
-LaurentFichterPartner an...linkedin.c...-
-Jean-Bapti...BessièresPartner an...linkedin.c...-
-Anne-LaureDelavergneMiddle Off...-
-EtienneRossignolSenior Inv...linkedin.c...-
-SofiaIoannidouPartner an...linkedin.c...-
-CamilleCollInvestment...linkedin.c...-
-PierreFlinInvestment...linkedin.c...-
-VincentBazzocchiDirector a...linkedin.c...-
-ArmelleOkoyeMiddle Off...-
-VanessaFavier-Kla...Chief Oper...linkedin.c...-
Show more

News 175

DateTitleDescription
14.03.2024Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC PipelineAndera Partners’ portfolio company Tubulis today announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. The round was co-led by EQT Life Sciences and Nextech Invest Ltd, on be...
14.03.2024Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZenecaAmolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced it has entered into a definitive agreement for AstraZeneca to acquire...
28.02.2024Andera Partners raises a final amount of € 233 million for Andera Smart Infra 1, its first fund dedicated to renewable energy transitionThe fundraising of Andera Smart Infra 1 highlights the strong interest of investors (including the European Investment Fund under InvestEU) in green infrastructure, resulting from renewable energy and ecological transition requirements. Thi...
21.02.2024MMI Raises $110 Million in Series C FinancingThe funds will support commercialization of the Symani® Surgical System in high-growth markets and continued investment in studies that generate clinical evidence and enable indication expansion. Investments will also accelerate advanced te...
12.02.20242023 Report – After a record year of investments and exits, Andera Partners sets a target of 7 to 8 billion Euros in AUM by 2028 and announces its European ambitionsAndera Partners, a leading private equity investment firm, had a particularly active 2023, with €627 million deployed (+25% as compared with 2022), €790 million in sales proceeds (+53%) and €680 million in new funds raised. Through its six ...
12.02.2024Internship Offer – Andera Life SciencesAndera Life Sciences, part of Andera Partners, is one of the leading Life Sciences venture capital teams in Europe and manages funds investing in therapeutics and medical devices. Through its Biodiscovery 6 fund, the team currently invests ...
24.01.2024Meogroup initiates a new development cycle with the support of Andera PartnersSince its inception by Richard Caron in 2005, Meogroup has specialised in providing operational support to its clients in their performance challenges. Based in France and present in Europe (Belgium, Italy, Spain, Switzerland, Luxembourg) a...
23.01.2024Andera Partners welcomes Sophie ELKRIEF as Business Development PartnerSophie ELKRIEF has worked her entire career in the financial sector. She started in investment banking (1996-2001) in London and New York (Salomon Smith Barney, JP Morgan) prior to moving to asset management firstly with Dexia Asset Managem...
18.01.2024Mistertemp’ group announces the reorganization of its shareholding: Andera Partners succeeds Montefiore InvestmentEstablished in 2009 and based in Paris, Mistertemp’ group provides a multichannel offer of HR services (temporary work and recruitment) in France and in Europe. The group initiated a radical change to its market based on an approach combini...
21.12.2023Spanish energy transition developer INGENOSTRUM accelerates, with a fund raising of 25M€ from Andera PartnersThe expert in renewable energy project development
Show more

Mentions in press and media 67

DateTitleDescription
14.01.2025Bioptimus brings its funding to $76M for the GPT of biologyAI foundation model company Bioptimus has raised a further $41 million cash injection, bringing its funding to $76 million. Bioptimus is redefining how we approach biological research by addressing a longstanding issue: the siloed nature of...
09.01.2025FIRE1: $120 Million Funding Raised For Transforming Heart Failure CareFIRE1 – a leading connected medical device solutions company – announced the completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. The fundin...
08.01.2025FIRE1 Secures $120M for Heart Failure Management PlatformWhat You Should Know: – FIRE1, a connected medical device company, announced it has secured $120M in funding to advance its mission to transform the lives of millions of people living with heart failure. The round was led by Polaris Partner...
07.01.2025FIRE1 Secures $120M FinancingFIRE1, a Dublin, Ireland-based connected medical device solutions company, raised $120M in funding. The round was led by Polaris Partners and Elevage Medical Technologies, joined by new investors Sands Capital and Longitude Capital, and exi...
07.01.2025FIRE1 heats up with $120M for its heart failure monitor implantThings are heating up for FIRE1, which posted a $120 million funding round to support its implant for tracking the hidden signs of heart failure. The Dublin-based company also announced that the FDA has handed down a breakthrough designatio...
09.11.2024Evommune Secures $115 Million to Tackle Chronic Inflammatory DiseasesIn the bustling world of biotechnology, Evommune has made waves. The Palo Alto-based company recently secured $115 million in Series C financing. This funding is a lifeline, aimed at advancing their clinical-stage pipeline focused on immune...
08.11.2024Evommune: $115 Million (Series C) Secured To Advance Clinical-Stage Pipeline Addressing Chronic Inflammatory DiseasesEvommune – a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases – announced the completion of a $115 million Series C financing. The funding was co-led by new investors RA...
30.07.2024Kestra Medical and T. Rowe Price: Pioneering Innovations in Healthcare and Sustainable FinanceIn the ever-evolving landscape of healthcare and finance, two companies are making waves. Kestra Medical Technologies is redefining cardiac care with its innovative wearable devices. Meanwhile, T. Rowe Price is spearheading sustainable inve...
29.07.2024Kestra Medical: Wearable Cardioverter Defibrillator Company Closes $196 Million In FundingKestra Medical Technologies (a privately held wearable medical device and digital healthcare company) announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its goals of ...
27.07.2024TRiCares: Medical Device Company Raises $50 Million In Series DTRiCares SAS, a privately held pioneer in the minimally invasive treatment of tricuspid regurgitation, announced it has raised $50 million (€46 million) in a Series D funding round. The funding round was raised from a single strategic inves...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In